华侨大学马俊杰--华侨大学医学院马俊杰--首页

个人简介

主要研究方向：

针对肿瘤等重大疾病的临床需求，基于致病靶点的结构和机制，通过合理物设计、合成和评价，获得兼具良好成药性和生物活性的“候选药物分子”。

承担课程：现代仪器分析（色谱部分）；药物化学；药物设计与合成。

科研项目（主持）：

1. 福建省自然科学基金面上项目，2021J01309，2021/11-2024/11。

2. 泉州市科技计划项目，2018C074R，2018/08-2021-08。

3. 华侨大学中青年教师科技创新资助计划，ZQN-PY519，2017/10-2021/10。

4. 福建省自然科学基金面上项目，2017J01143，2017/04-2020/04。

5. 国家自然科学青年基金，81602970，2017/01-2019/12。

科研项目（参与）：

1. 国家自然科学基金面上项目，21772047，2018/01-2022/01，第三

2. 福建省高校产学合作项目，2019Y4007，2019/06-2022/06，第二

3. 福建省高校产学合作项目，2021Y4012，2021/11-2024/11，第二

4. 福建省自然科学基金面上项目，2021J01321，2021/11-2024/11，第三

5. 泉州市科技计划项目，2018C072R，2018/10-2021/1，第二

6. 泉州市科技计划项目，2019C064R，2019/09-2022/09，第三

科研论文

(第一作者/通讯作者)：

1. He Li, Yali Gao, Xin Ni, Yizu Xiong, Peixi Zhang, Han Liu, Xingye Wu, Dandan Tong, Cuifang Wang* & Junjie Ma*. Design, synthesis and biological evaluation of 5H-[1,2,4]triazino[5,6-b]indole derivatives bearing a pyridinocycloalkyl moiety as iron chelators. Mol Divers (2024). https://doi.org/10.1007/s11030-024-10840-w.

2. X. Wu, H. Li, H. Liu, X. Ding, X. Chen, C. Yin, Y. Gao*, J. Ma*, Design, Synthesis and Evaluation of 8-(o-Tolyl)quinazoline Derivatives as Small-Molecule PD-1/PD-L1 Antagonists. ACS Medicinal Chemistry Letters, 2024, 15, 518–523.

3. Yali Gao*, Fei Li, Xin Ni, Siwang Yang, Han Liu, Xingye Wu, Jieqing Liu* and Junjie Ma*. Design, synthesis and biological evaluation of VEGFR-2/HDAC dual inhibitors as multitargeted antitumor agents based on fruquintinib and vorinostat. RSC Adv., 2023,13, 28462-28480.

4. Roufen Chen, Yali Gao, Han Liu, He Li, Wenfa Chen* and Junjie Ma*. Advances in research on 3C-like protease (3CLpro) inhibitors against SARS-CoV-2 since 2020. RSC Med. Chem., 2023,14, 9-21.

5. He Li, Yali Gao*, and Junjie Ma*. Advances in nonclassical phenyl bioisosteres for drug structural optimization. Future Medicinal Chemistry 2022 14, 1681-1692.

6. Yu. Wang, Huang. Kun, Yali. Gao, Dandan. Yuan, Lin. Ling, Jieqing. Liu, Sihai. Wu, Roufen. Chen, He. Li, Yizu. Xiong, Han. Liu, Junjie. Ma*, Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction, European Journal of Medicinal Chemistry, 2022, 229, 113998.

7. Roufen Chen, Dandan Yuan, JunJie Ma*, Advances of biphenyl small-molecule inhibitors targeting PD-1/PD-L1 interaction in cancer immunotherapy, Future Med. Chem., 2022, 14(2), 97-113.

8. Junjie Ma*, Xin Ni, Yali Gao, Kun Huang, Jiaan liu, Yu Wang, Roufen Chen, Cuifang Wang*. Identification and biological evaluation of novel benzothiazole derivatives bearing a pyridine-semicarbazone moiety as apoptosis inducers via activation of procaspase-3 to caspase-3, MedChemComm, 2019, 10(3), 465-477.

9. Junjie Ma*, Xin Ni, Yali Gao, Kun Huang, Yu Wang, Jiaan Liu, Guowei Gong*. Semicarbazone derivatives bearing phenyl moiety: synthesis, anticancer activity, cell cycle, apoptosis-inducing and metabolic stability study, Chemical & Pharmaceutical Bulletin, 2019, 67(4), 351-360.

10. Junjie Ma*, Kun Huang, Xin Ni, Roufen Chen, Boxuan Xu & Cuifang Wang*. Design, Synthesis, Biological Activity and Molecular Docking Study of Coumarin Derivatives Bearing 2-Methyl-Biphenyl Moiety, Chem. Res. Chinese Universities, 2019, 35, 410-417.

11. 马俊杰*, 倪欣, 黄坤, 王瑜, 含苯并噻唑/苯基片段的香豆素衍生物的设计、合成及抗肿瘤活性研究, Acta Pharmaceutica Sinica(药学学报), 2019, 54(3), 514 −521.

12. 倪欣, 黄坤, 马俊杰*. Procaspase-3 小分子激活剂的研究进展, 中国现代应用药学, 2019, 36(3), 368-371.

13. Junjie Ma, Guanglong Bao, Limei Wang, Wanting Li, Boxuan Xu, XinZhai, Ping Gong^*. Design, synthesis, biological evaluation and preliminary mechanism study of novel benzothiazole derivatives bearing indole-based moiety as potent antitumor agents, European Journal of Medicinal Chemistry, 2015, 96, 173-186.

14. MA Junjie, HU Gang, XIE Lijun, CHEN Lei, XU Boxuan, GONG Ping^*. Design, Synthesis and Biological Evaluation of Novel Benzothiazole Derivatives Bearing Semicarbazone Moiety as Antitumor Agents, Chemical Research in Chinese Universities, 2015, 31(6), 958-963.

15. Junjie Ma, Dong Chen, Kuan Lu, Lihui Wang, Xiaoqi Han, Yanfang Zhao, Ping Gong^*. Design, synthesis, and structureeactivity relationships of novel benzothiazole derivatives bearing the ortho-hydroxy N-carbamoylhydrazone moiety as potent antitumor agents, European Journal of Medicinal Chemistry, 2014, 86, 257-269.

16. Junjie Ma, Guangyan Zhang, Xiaoqi Han, Guanglong Bao, Lihui Wang, Xin Zhai,and Ping Gong^*. Synthesis and Biological Evaluation of Benzothiazole Derivatives Bearing the ortho-Hydroxy-N-acylhydrazone Moiety as Potent Antitumor Agents, Arch. Pharm. Chem. Life Sci, 2014, 347(12), 936-949.

（参与作者）

1. Si-Hai Wu*, Rong Yang, Bin Sun, Jian-Hong Tang, Zhong-Liang Gong, Junjie Ma, Lianhui Wang, Jieqing Liu, Dian-Xue Ma, Jiang-Yang Shao*, and Yu-Wu Zhong*. Dual-Emissive Tris-Heteroleptic Ruthenium Complexes: Tuning the DNA-Triggered Ratiometric Emission Response by Ancillary Ligands. Inorg. Chem. 2021, 60, 19, 14810–14819.

2. Si-Hai Wu*, Jiang-Yang Shao, Zifeng Zhao, Junjie Ma, Rong Yang, Na Chen, Jian-Hong Tang*, Zuqiang Bian, and Yu-Wu Zhong*. Ligand Engineering toward Deep Blue Emission in Nonplanar Terdentate Platinum(II) Complexes. Organometallics 2021, 40, 2, 156–165.

3. Shao, Jiang-Yang; Wu, Si-Hai; Ma, Junjie; Gong, Zhong-Liang; Sun, Tian-Ge; Jin, Yulong; Yang, Rong; Sun, Bin; Zhong, Yu-Wu. Ratiometric detection of amyloid-beta aggregation by a dual-emissive tris-heteroleptic ruthenium complex, Chem. Commun., 2020, 56, 2087-2090.

4. Jie-Qing Liu*, Ying Xu, Qin Xiao, Jin-Di Huang, Jun-Jie Ma, Chen-Lei Lian, Mei-Ying Huang, Zhen-bo Du and Cui-Fang Wang*, Dimericursones A and B: two unprecedented hexacyclic dimeric diterpenoids from the root barks of Jatropha curcas, Org. Biomol. Chem., 2018,16, 8305-8310.

授权专利：

1. 马俊杰，刘接卿，袁丹丹，陈柔芬，一种含异羟肟酸结构的联苯类化合物及其应用，ZL 202211121782.5.

2. 马俊杰，王瑜，陈柔棻，刘接卿，吴四海，一种苯并芳杂环化合物及其用途，ZL 202110222639. 4.

3. 马俊杰, 倪欣. 一种吲哚类衍生物及其应用, ZL 201911217790.8.

4. 马俊杰, 黄坤, 倪欣, 陈柔棻, 余楚丹, 闫琦慧, 陈思颖, 侯晓林. 一种香豆素类衍生物及其应用, ZL 201811131802.0.